SCNX (Scienture Holdings) 3-Year Sortino Ratio: -0.58 (As of Sep. 08, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SCNX Scienture Holdings Inc SCNX
45 GF Score
Price $0.37
GF Value $0.52
Valuation Modestly Undervalued
! 9 Warning Signs
View Full Analysis

What is Scienture Holdings 3-Year Sortino Ratio?

Scienture Holdings SCNX +0.87% 45 3-Year Sortino Ratio is -0.58 as of Sep. 08, 2026. GuruFocus rates SCNX with a GF Score™ of 45/100 and a GF Value™ of $0.52 (Modestly Undervalued). The stock has 9 warning signs investors should review.

The 3-Year Sortino Ratio measures the additional return that an investor receives per unit of the downside risk over the past three years. As of today (2026-09-08), Scienture Holdings's 3-Year Sortino Ratio is -0.58.


Scienture Holdings  (NAS:SCNX) 3-Year Sortino Ratio Explanation

The 3-Year Sortino Ratio inidicates the risk-adjusted return of an investment over the past three year. It is calculated as the annualized result of the average three-year monthly excess returns divided by the standard deviation of negative returns in the three-year period. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

Differnt from the Sharpe Ratio that penalizes both upside and downside volatility equally, the Sortino Ratio penalizes only those returns falling below a user-specified target or required rate of return. The expected returns here is set to the risk-free rate as well.


Scienture Holdings 3-Year Sortino Ratio Related Terms


SCNX vs PMHS, HEWA, BLMH: 3-Year Sortino Ratio Comparison

For the Pharmaceutical Retailers subindustry, Scienture Holdings's 3-Year Sortino Ratio, along with its competitors' market caps and 3-Year Sortino Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scienture Holdings 3-Year Sortino Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Scienture Holdings's 3-Year Sortino Ratio distribution charts can be found below:

* The bar in red indicates where Scienture Holdings's 3-Year Sortino Ratio falls into.


SCNX
45GF Score
Scienture Holdings Inc SCNX
3-Year Sortino Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scienture Holdings 3-Year Sortino Ratio Calculation

The 3-Year Sortino Ratio measures the risk-adjusted return of an investment asset or portfolio in the last three year, focusing specifically on downside risk rather than total risk. A stock / portfolio's 3-Year Sortino Ratio can be calculated by dividing the difference between the three-year average monthly returns of the investment and the risk-free rate, by the standard deviation of the downside risks over the past three year.

A downside risk is a potential loss from the asset or investment. The Downside risk here is measured by the downside deviation, which is the standard deviation of negative returns.

Frequently Asked Questions Learn more about 3-Year Sortino Ratio →
What does a 3-Year Sortino Ratio of -0.58 mean?
Scienture Holdings (SCNX) has a 3-Year Sortino Ratio of -0.58 as of Sep. 08, 2026. 3-Year Sortino Ratio measures the additional return that an investor receives per unit of the downside risk over the past three years. View historical data for Scienture Holdings and its competitors.
Is Scienture Holdings' 3-Year Sortino Ratio too high?
Scienture Holdings' current 3-Year Sortino Ratio is -0.58. Overall, Scienture Holdings has a GF Score™ of 45/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Scienture Holdings' 3-Year Sortino Ratio compare to PMHS and HEWA?
Scienture Holdings' 3-Year Sortino Ratio of -0.58 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Sortino Ratio for a Healthcare Providers & Services company?
A good 3-Year Sortino Ratio depends on the Healthcare Providers & Services industry context. However, 3-Year Sortino Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Sortino Ratio mean?
A high 3-Year Sortino Ratio can signal that a stock is expensive relative to its fundamentals. 3-Year Sortino Ratio measures the additional return that an investor receives per unit of the downside risk over the past three years. View historical data for Scienture Holdings and its competitors. Scienture Holdings's current 3-Year Sortino Ratio is -0.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scienture Holdings stock overvalued right now?
Based on GuruFocus' analysis, Scienture Holdings (SCNX) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.52, compared to a current price of $0.37 — trading 29.2% below its estimated fair value. The current 3-Year Sortino Ratio is -0.58. Scienture Holdings' overall GF Score™ is 45/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Sortino Ratio calculated?
3-Year Sortino Ratio is calculated from a company's financial statements. For Scienture Holdings (SCNX), the current 3-Year Sortino Ratio is -0.58 as of Sep. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Scienture Holdings (SCNX) Overvalued in 2026?

Based on GuruFocus' analysis, Scienture Holdings stock appears to be undervalued. The current stock price of $0.37 is trading 29.2% below its estimated GF Value™ of $0.52. GuruFocus considers Scienture Holdings to be Modestly Undervalued.

Key valuation signals for SCNX:

  • 3-Year Sortino Ratio: -0.58
  • GF Value™: $0.52 vs. price of $0.37 (29.2% below fair value)
  • GF Score™: 45/100 with 9 warning signs

No single metric tells the full story. See the SCNX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Scienture Holdings Business Description

Other Exchanges 4E4:Germany
Address 20 Austin Boulevard, Commack, NY, USA, 11725
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.
45GF Score

Get the complete analysis for SCNX

3-Year Sortino Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.37
Price
$0.52
GF Value